11.9%), this reduction was marginally non-significant at 28 days (11.4% vs. 15.2%, HR 0.73, 95% CI 0.52 to 1.03) [ 97 ].
← all excerpts
HIV and COVID-19 Co-Infection: Epidemiology, Clinical Characteristics, and Treatment.
1
—
—
11.9%), this reduction was marginally non-significant at 28 days (11.4% vs. 15.2%, HR 0.73, 95% CI 0.52 to 1.03) [ 97 ].